» Articles » PMID: 35517424

Prognostic Value of the Combination of HB (hemoglobin) and CEA in Resectable Gastric Cancer

Overview
Journal J Cancer
Specialty Oncology
Date 2022 May 6
PMID 35517424
Authors
Affiliations
Soon will be listed here.
Abstract

In order to investigate the prognostic value of a novel biomarker combining serum carcinoembryonic antigen (CEA) and hemoglobin (HB) levels in patients with resectable gastric cancer. This retrospective study assessed the relationship between CEA, hemoglobin levels, a novel combined prognostic biomarker (HB-CEA) and clinicopathological features of gastric cancer. Their prognostic values in gastric cancer were also analyzed. This retrospective study evaluated the CEA, hemoglobin levels and clinicopathological features of patients with resectable gastric cancer. Kaplan-Meier curves, univariate and multivariate Cox proportional models were used to determine the prognostic significance of these factors for overall survival (OS) in the training and validation sets (n=353 and n=388, respectively). Based on optimal cutoff values of CEA and hemoglobin (3.395 ng/mL and 125.5 g/L, respectively), patients were stratified into three groups: HB-CEA=0, 1, and 2 (CEA <3.395 ng/mL and HB ≥125.5 g/L; CEA ≥3.395 ng/mL or HB <125.5 g/L; and CEA ≥3.395 ng/mL and HB <125.5 g/L, respectively). The area under the curve was larger for HB-CEA than for either HB or CEA alone (training set: 0.677, 0.650, and 0.629; validation set: 0.670, 0.605, and 0.605, respectively). HB-CEA was strongly associated with age, tumor size, differentiation, pathological TNM stage (pTNM), depth of tumor invasion, lymph node metastasis, and survival status (all <0.05). A higher HB-CEA score correlated with poor survival (Kaplan-Meier curves, all <0.05). Multivariate analysis showed that HB-CEA was an independent prognostic factor for OS (<0.05). Preoperative HB-CEA, as a potential novel hematological biomarker, can predict the progression of gastric cancer and the prognosis of patients, and is of great value in guiding clinical practice. Therefore, patients with a higher HB-CEA score should receive more extensive follow-up for early detection and intervention of tumor progression.

Citing Articles

Novel affibody molecules targeting the AXL extracellular structural domain for molecular imaging and targeted therapy of gastric cancer.

Zhang H, Zheng M, Cai Y, Kamara S, Chen J, Zhu S Gastric Cancer. 2024; 28(2):174-186.

PMID: 39644434 PMC: 11842530. DOI: 10.1007/s10120-024-01568-5.


Serum tumor markers (carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4, carbohydrate antigen 24-2, ferritin) and gastric cancer prognosis correlation.

Zhu J, Gong L, Wang Q World J Gastrointest Surg. 2024; 16(9):2808-2814.

PMID: 39351575 PMC: 11438793. DOI: 10.4240/wjgs.v16.i9.2808.


Association between admission hemoglobin level and prognosis in sepsis patients based on a critical care database.

Peng H, Su Y, Luo J, Ding N Sci Rep. 2024; 14(1):5212.

PMID: 38433267 PMC: 10909867. DOI: 10.1038/s41598-024-55954-1.

References
1.
Cordella C, Luebbers H, Rivelli V, Gratz K, Kruse A . An evaluation of the preoperative hemoglobin level as a prognostic factor for oral squamous cell carcinoma. Head Neck Oncol. 2011; 3:35. PMC: 3199902. DOI: 10.1186/1758-3284-3-35. View

2.
Yuruk K, Bartels S, Milstein D, Bezemer R, Biemond B, Ince C . Red blood cell transfusions and tissue oxygenation in anemic hematology outpatients. Transfusion. 2011; 52(3):641-6. DOI: 10.1111/j.1537-2995.2011.03312.x. View

3.
Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G . Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer. 2017; 17(1):737. PMC: 5679342. DOI: 10.1186/s12885-017-3738-y. View

4.
Kim E, Lee J, Yoo H, Park C, Song K . The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?. Ann Surg Oncol. 2015; 22(13):4363-70. DOI: 10.1245/s10434-015-4518-z. View

5.
Jung D, Lee H, Han D, Suh Y, Kong S, Lee K . Impact of perioperative hemoglobin levels on postoperative outcomes in gastric cancer surgery. Gastric Cancer. 2012; 16(3):377-82. DOI: 10.1007/s10120-012-0196-8. View